Developing a new device to monitor heart failure treatment remotely
Initial Animal Validation of a Multimodal Molecular Monitor for Heart Failure Treatment
This study is testing a new device that can continuously check important health markers in heart failure patients after they leave the hospital, so they can be monitored from home and avoid frequent trips to the doctor.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kilele Health INC. NIH-funded |
| Lab location | 1 site (Oakwood, United States) |
| Project ID | NIH-11072993 on NIH RePORTER |
What this research studies
This research focuses on creating a continuous molecular monitor that can track important biomarkers like NT-proBNP and potassium in heart failure patients. The goal is to enable remote monitoring during the critical 30-90 days after hospital discharge, reducing the need for frequent outpatient visits. By leveraging technology, this approach aims to improve treatment outcomes and patient management in a more decentralized care setting. The research is based on findings from the STRONG-HF trial, which highlighted the importance of these biomarkers in managing heart failure effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients recently diagnosed with heart failure who are in the post-discharge phase.
Not a fit: Patients with stable heart failure who are not recently discharged may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better management of heart failure, reducing hospital readmissions and improving patient outcomes.
How similar studies have performed: Previous studies have shown success in remote monitoring for chronic conditions, indicating a promising avenue for this novel approach in heart failure management.
Where this research is happening
Oakwood, United States
- Kilele Health INC. — Oakwood, United States (Active)
Researchers
- Principal investigator: Schreiber, Sven — Kilele Health INC.
- Study coordinator: Schreiber, Sven
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.